Article Text

PDF

Basic science
P36 Block of interferon γ and co-culture with smDCs enhance antigen-specific T-reg suppression ability in autoimmune hepatitis type 2
  1. M S Longhi,
  2. G Mieli-Vergani,
  3. Y Ma,
  4. D Vergani
  1. Liver Studies and Transplantation, King's College Hospital, UK

Abstract

Introduction CD4posCD25high regulatory T-cells (T-regs), central to immune homeostasis, are impaired in autoimmune hepatitis type 2 (AIH-2), a severe disease often leading to end-stage liver damage despite immunosuppression. T-regs specific for cytochrome P450IID6 (CYP2D6), the target autoantigen in AIH-2, can be expanded in vitro and exert a stronger suppressor function over damaging effector T-cells than non antigen-specific T-regs.

Aim To explore the mechanisms controlling antigen-specific T-reg suppressor function in AIH-2.

Method 13 AIH-2 patients positive for the HLA-DR7 and DR3 predisposing MHC alleles, were studied. Peptide-pulsed semi-mature dendritic cells (smDCs) were obtained from CD14pos cells following treatment with IL-4, GM-CSF, interferon-λ and CYP2D6 peptides. CYP2D6-T-regs were obtained after CD4posCD25high cell purification from CD14neg cells cultured for 8 days in presence of CYP2D6 peptide, high dose interleukin-2 (IL-2) and T-cell expander. Frequency of interferon (IFN)-γ, IL-2, IL-17, IL-4, IL-10 and TGF-β producing cells within CYP2D6-T-regs was tested before and after 2-day co-culture with smDCs (smDC-CYP2D6-T-regs) by intracellular staining; suppressor function was determined by proliferation assay after T-reg addition to CD25neg target cells.

Results There was no difference in the frequency of IL-2, IL-17, IL-4, IL-10 and TGF-β producing CYP2D6-T-regs in the absence or presence of smDCs, while IFN-γ-producing cells were more frequent in the absence of smDCs (1.39±0.3 vs 0.4±0.1; p=0.046). Treatment with anti-IFN-γ neutralising antibody decreased the frequency of IFN-γ-producing cells within CYP2D6-T-regs to 0.46±0.2 (p=0.041) and enhanced their suppressor function over CD25neg cell proliferation from 23% to 45.6% (p=0.04), this value being similar to that obtained after adding smDC-CYP2D6-T-regs (50%). As engagement of the signalling molecule B7-H1 on smDCs inhibits IFN-γ secretion, we tested whether its blockage affects the number of IFN-γ-producing cells and/or smDC-CYP2D6-T-reg suppressor function. Interestingly, blockage of B7-H1 did not affect smDC-T-regs ability to suppress despite incrementing the frequency of IFN-γ-producing cells (1.63±0.08; p<0.001), suggesting that smDCs enhance antigen-specific T-reg function independently of IFN-γ.

Conclusion In AIH-2 T-reg suppression ability is enhanced by control of IFN-γ production and by co-culture with peptide-pulsed smDCs. These manoeuvres should be considered to obtain highly potent clinical-grade T-regs for immunotherapy. The mechanism through which smDCs augment suppression remains to be clarified.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.